|
Volumn 22, Issue 15, 2014, Pages 4223-4232
|
Identification and development of 2-methylimidazo[1,2-a]pyridine-3- carboxamides as Mycobacterium tuberculosis pantothenate synthetase inhibitors
|
Author keywords
2 Methylimidazo 1,2 a pyridine 3 carbohydrazide; Cytotoxicity; Pantothenate synthetase; Tuberculosis
|
Indexed keywords
2 METHYL N PHENYLIMIDAZO[1,2 A]PYRIDINE 3 CARBOXAMIDE;
2 METHYL N' (3 NITROBENZOYL)IMIDAZO[1,2 A]PYRIDINE 3 CARBOHYDRAZIDE;
2 METHYL N' (3,4,5 TRIMETHOXYBENZYLIDENE)IMIDAZO[1,2 A]PYRIDINE 3 CARBOHYDRAZIDE;
2 METHYL N' (4 METHYLBENZOYL)IMIDAZO[1,2 A]PYRIDINE 3 CARBOHYDRAZIDE;
2 METHYL N' (4 METHYLBENZYLIDENE)IMIDAZO[1,2 A]PYRIDINE 3 CARBOHYDRAZIDE;
2 METHYL N' (4 NITROBENZYLIDENE)IMIDAZO[1,2 A]PYRIDINE 3 CARBOHYDRAZIDE;
2 METHYL N' (4 PHENOXYBENZOYL)IMIDAZO[1,2 A]PYRIDINE 3 CARBOHYDRAZIDE;
2 METHYL N' [4 (TRIFLUOROMETHYL)BENZYLIDENE]IMIDAZO[1,2 A]PYRIDINE 3 CARBOHYDRAZIDE;
2 METHYLIMIDAZO [1,2 A]PYRIDINE 3 CARBOXAMIDE DERIVATIVE;
2 METHYLIMIDAZO[1,2 A]PYRIDINE 3 CARBOHYDRAZIDE;
2 METHYLIMIDAZO[1,2 A]PYRIDINE 3 CARBOXYLIC ACID;
CARBOXYLIC ACID DERIVATIVE;
ENZYME INHIBITOR;
ISONIAZID;
N' (1 NAPHTHOYL) 2 METHYLIMIDAZO[1,2 A]PYRIDINE 3 CARBOHYDRAZIDE;
N' (2 METHOXYBENZOYL) 2 METHYLIMIDAZO[1,2 A]PYRIDINE 3 CARBOHYDRAZIDE;
N' (2,4 DICHLOROBENZOYL) 2 METHYLIMIDAZO[1,2 A]PYRIDINE 3 CARBOHYDRAZIDE;
N' (3,5 DINITROBENZOYL) 2 METHYLIMIDAZO[1,2 A]PYRIDINE 3 CARBOHYDRAZIDE;
N' (4 BROMOBENZYLIDENE) 2 METHYLIMIDAZO[1,2 A]PYRIDINE 3 CARBOHYDRAZIDE;
N' (4 FLUOROBENZYLIDENE) 2 METHYLIMIDAZO[1,2 A]PYRIDINE 3 CARBOHYDRAZIDE;
N' (4 HYDROXYBENZYLIDENE) 2 METHYLIMIDAZO[1,2 A]PYRIDINE 3 CARBOHYDRAZIDE;
N' (4 METHOXYBENZYLIDENE) 2 METHYLIMIDAZO[1,2 A]PYRIDINE 3 CARBOHYDRAZIDE;
N' (CYCLOHEXANECARBONYL) 2 METHYLIMIDAZO[1,2 A]PYRIDINE 3 CARBOHYDRAZIDE;
N' (FURAN 2 CARBONYL) 2 METHYLIMIDAZO[1,2 A]PYRIDINE 3 CARBOHYDRAZIDE;
N' BENZOYL 2 METHYLIMIDAZO[1,2 A]PYRIDINE 3 CARBOHYDRAZIDE;
N' BENZYLIDENE 2 METHYLIMIDAZO[1,2 A]PYRIDINE 3 CARBOHYDRAZIDE;
N' [4 (BENZYLOXY)BENZYLIDENE] 2 METHYLIMIDAZO[1,2 A]PYRIDINE 3 CARBOHYDRAZIDE;
PANTOTHENATE SYNTHETASE;
PANTOTHENIC ACID;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
AMIDE;
BACTERIAL PROTEIN;
IMIDAZO(1,2-A)PYRIDINE;
PEPTIDE SYNTHASE;
PYRIDINE DERIVATIVE;
TUBERCULOSTATIC AGENT;
ANIMAL CELL;
ANTIBACTERIAL ACTIVITY;
ARTICLE;
BINDING AFFINITY;
CONCENTRATION RESPONSE;
CONTROLLED STUDY;
DRUG CYTOTOXICITY;
DRUG IDENTIFICATION;
DRUG STRUCTURE;
ENZYME INHIBITION;
HIGH THROUGHPUT SCREENING;
HYDROGEN BOND;
IC 50;
IN VITRO STUDY;
MOLECULAR DOCKING;
MYCOBACTERIUM TUBERCULOSIS;
NONHUMAN;
STRUCTURE ACTIVITY RELATION;
ANIMAL;
ANTAGONISTS AND INHIBITORS;
BINDING SITE;
CELL LINE;
CELL SURVIVAL;
CHEMISTRY;
DRUG EFFECTS;
ENZYME ACTIVE SITE;
ENZYMOLOGY;
METABOLISM;
MICROBIAL SENSITIVITY TEST;
MOLECULAR DYNAMICS;
MOUSE;
SYNTHESIS;
AMIDES;
ANIMALS;
ANTITUBERCULAR AGENTS;
BACTERIAL PROTEINS;
BINDING SITES;
CATALYTIC DOMAIN;
CELL LINE;
CELL SURVIVAL;
ENZYME INHIBITORS;
MICE;
MICROBIAL SENSITIVITY TESTS;
MOLECULAR DYNAMICS SIMULATION;
MYCOBACTERIUM TUBERCULOSIS;
PEPTIDE SYNTHASES;
PYRIDINES;
STRUCTURE-ACTIVITY RELATIONSHIP;
|
EID: 84905123430
PISSN: 09680896
EISSN: 14643391
Source Type: Journal
DOI: 10.1016/j.bmc.2014.05.038 Document Type: Article |
Times cited : (30)
|
References (14)
|